Hamilton Thorne Ltd
XTSX:HTL

Watchlist Manager
Hamilton Thorne Ltd Logo
Hamilton Thorne Ltd
XTSX:HTL
Watchlist
Price: 1.45 CAD 4.32% Market Closed
Market Cap: CA$211.5m

Net Margin

0.8%
Current
Declining
by 0.8%
vs 3-y average of 1.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0.8%
=
Net Income
$717.8k
/
Revenue
$63m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0.8%
=
Net Income
CA$717.8k
/
Revenue
$63m

Peer Comparison

Country Company Market Cap Net
Margin
US
Hamilton Thorne Ltd
XTSX:HTL
212.4m CAD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.1B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
44rd
Based on 15 072 companies
44rd percentile
0.8%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Hamilton Thorne Ltd
Glance View

Market Cap
211.5m CAD
Industry
Health Care

Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. The company is headquartered in Beverly, Massachusetts. The company went IPO on 2007-07-10. The firm's products lines include precision laser devices, imaging systems, micromanipulation systems, air purification systems, incubators, control rate freezers, and lab monitoring systems. Its GM501 product provides the In Vitro Fertilization (IVF)lab with a cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation. Its services offers a range of user needs, ranging from equipment service contract and maintenance programs, quality control testing services to manufacturers of medical devices, culture media and consumables used in IVF labs, and laboratory design and installation services. The firm's brands include Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event.

HTL Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
0.8%
=
Net Income
$717.8k
/
Revenue
$63m
What is Hamilton Thorne Ltd's current Net Margin?

The current Net Margin for Hamilton Thorne Ltd is 0.8%, which is below its 3-year median of 1.7%.

How has Net Margin changed over time?

Over the last 3 years, Hamilton Thorne Ltd’s Net Margin has decreased from 1.6% to 0.8%. During this period, it reached a low of 0.9% on Jun 30, 2023 and a high of 4.8% on Jun 30, 2021.

Back to Top